Application of double filtration plasmapheresis(DFPP) in reducing the risks of SLE

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CRIS

Registry ID

KCT0000346

Enrollment

Registered

2012-02-09

Start date

2011-12-14

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : double filtration plasma pheresis implemented each 2 times

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the subjects who are 20-65 aged, spontaneously consent this study and put their signature on the consent form, take immunosupressants at present, and are relevant below 2 of 4 matters 1) antinuclear Ab + 2) anti double strand DNA Ab + 3) antimitochodrial Ab + 4) Hs-CRP >= 1.0

Exclusion criteria

Exclusion criteria: 1) severe complications such as liver failure, heart failure, diseases related to blood. 2) pregnant 3)body weight <= 45 kg 4)shock events 5)bleeding tendency 6)steroids sensitive reaction 7)communcation disability 8)recent blood donation

Design outcomes

Primary

Measure	Time frame
self antibody range	—

Secondary

Measure	Time frame
quality of life	—

Countries

Korea, Republic of

Contacts

Public ContactHye-won Park

Seoul National University Hospital

Outcome results